0011980

Roche launches Bluetooth-enabled self-testing device to check blood clotting in EU

pharmafile | May 31, 2016 | News story | Manufacturing and Production, Research and Development, Sales and Marketing HealthTech, Heart Conditions, Roche, blood clotting, product launch 

Swiss drug firm Roche (Six: ROG) has launched a blood-clott monitoring system for patients with different heart conditions.

The CoaguChek INRange system is a Bluetooth enabled home health device that helps patients and their healthcare providers (HCP) monitor coagulation status and the ability to monitor Vitamin K Antagonist (VKA) therapy, the company said in a statement.

Roland Diggelmann, chief operating officer, Roche Diagnostics, said: “As healthcare systems face continued pressure to deliver improved access to care at a lower cost, increased connectivity between HCPs and patients becomes even more important. This innovative technology continues the CoaguChek legacy of setting the standard in coagulation monitoring by providing high quality, convenient care, while optimising outcomes for patients. This is another proof point towards our aim to position patient self-testing as the standard of care to monitor VKA therapy.”

Vitamin K Antagonists (VKAs) are indicated to patients for a variety of conditions, including atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE), and the presence of a mechanical heart valve (MHV).

To best monitor the efficacy of VKAs, the prothrombin time PT (INR) needs to be frequently measured. 

Anjali Shukla

Related Content

Roche’s Alecensa approved by FDA as lung cancer treatment

Roche has announced that the US Food and Drug Administration (FDA) has approved Alecensa (alectinib) …

Genentech’s Columbi meets primary endpoint in phase 3 trial for lymphoma treatment

Genentech, part of the Roche Group, has announced that its phase 3 STARGLO trial has …

Baxter expands US portfolio with new injectables

Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of …

Latest content